The Lancet Inf. Dis.: Coronavac COVID-19 vaccine safe in children and adolescents and triggers antibodies
(The Lancet) Two doses of CoronaVac are safe and provoke a strong antibody response among children and adolescents aged 3-17 years, according to a randomised controlled trial of 550 young people published in The Lancet Infectious Diseases journal.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Children | COVID-19 | Infectious Diseases | Vaccines